European Union conference on poverty-related diseases research

The Lancet Infectious Diseases

Volumn 9, Issue 6, 2009, Pages 334-337

  Gryseels, Bruno ^a   Zumla, Alimuddin ^b   Troye Blomberg, Marita ^c   Kieny, Marie Paule ^d   Quaglio, Gianluca ^e   Holtel, Andreas ^e   Laang, Hannu ^e   Romaris, Manuel ^e   De Magistris, Maria Teresa ^e   Nuez, Ana Nieto ^e   Olesen, Ole F ^e   Ghalouci, Rachida ^e   Lönnroth, Anna ^e  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e EUROPEAN COMMISSION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; BIOLOGICAL MARKER; MALARIA VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; EUROPE; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; INNATE IMMUNITY; LETTER; MALARIA; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; POVERTY; PRIORITY JOURNAL; TUBERCULOSIS;

AIDS VACCINES; BIOMEDICAL RESEARCH; EUROPEAN UNION; HIV INFECTIONS; HUMANS; MALARIA; MALARIA VACCINES; POVERTY; TUBERCULOSIS; TUBERCULOSIS VACCINES; WORLD HEALTH;

EID: 65649140102     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(09)70129-X     Document Type: Letter

References (17)

1. Communication from the Commission to the Council and the European Parliament-a European programme for action to confront HIV/AIDS, malaria and tuberculosis through external action (2007-2011). http://europa.eu/scadplus/leg/en/lvb/r12537.htm (accessed April 20, 2009).
2. European Commission. Combatting deadly diseases: EU funded projects on poverty-related diseases HIV/AIDS, malaria, tuberculosis. 3rd edn (2006), Office for official publications of the European Communities, Luxemburg. http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/doc/catalogue-3rdcall_en.pdf (accessed April 20, 2009).
3. European Commission-research health. Challenges for the future: research on HIV/AIDS malaria and tuberculosis. http://ec.europa.eu/research/conferences/2008/poverty-related-diseases/index_en.html (accessed April 20, 2009).
4. Merson M.H., O'Malley J., Serwadda D., and Apisuk C. The history and challenge of HIV prevention. Lancet 372 (2008) 475-488
5. Girard M.P., and Bansal G.P. HIV/AIDS vaccines: a need for new concepts?. Int Rev Immunol 27 (2008) 447-471
6. Dau B., and Holodniy M. Novel targets for antiretroviral therapy: clinical progress to date. Drugs 69 (2009) 31-50
7. Hirsch J.S. Gender, sexuality, and antiretroviral therapy: using social science to enhance outcomes and inform secondary prevention strategies. AIDS 21 suppl (2007) S21-S29
8. Laufer M.K. Monitoring antimalarial drug efficacy: current challenges. Curr Infect Dis Rep 11 (2009) 59-65
9. Galinski M.R., and Barnwell J.W. Plasmodium vivax: who cares?. Malar J 7 suppl (2008) S9
10. Jenwitheesuk E., Horst J.A., Rivas K.L., Van Voorhis W.C., and Samudrala R. Novel paradigms for drug discovery: computational multitarget screening. Trends Pharmacol Sci 29 (2008) 62-71
11. Black IV W.C., Gorrochetegui-Escalante N., Randle N.P., and Donnelly M.J. The yin and yang of linkage disequilibrium: mapping of genes and nucleotides conferring insecticide resistance in insect disease vectors. Adv Exp Med Biol 627 (2008) 71-83
12. WHO. Global tuberculosis control-epidemiology, strategy, financing: WHO report 2009 (2009), World Health Organization, Geneva. http://www.who.int/tb/publications/global_report/en/ (accessed April 20, 2009).
13. Wallis R.S., Doherty T.M., Onyebujoh P., et al. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis 9 (2009) 162-172
14. Hoft D.F. Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet 372 (2008) 164-175
15. Global alliance for TB drug development. Pathway to patients: charting the dynamics of the global TB drug market (2007), Global alliance for TB drug development, New York. http://www.bvgh.org/documents/TB_Alliance_Pathway_to_Patients_FINAL.pdf (accessed April 20, 2009).
16. Communication from the Commission to the European Parliament and the Council on the progress report on the 'European and Developing Countries Clinical Trials Partnership' Programme. COM/2008/688/. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SEC:2008:2724:FIN:EN:PDF (accessed April 20, 2009).
17. Annual Report on research and technological development activities of the European Union in 2007 (2008), European Commission, Brussels. http://ec.europa.eu/research/reports/2008/index_en.html (accessed April 20, 2009).